MedTrace Logo

Prehabilitation in Childhood Soft Tissue or Bone Sarcomas

NCT06743958 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2025-05-28

No results posted yet for this study

Summary

This study aims to investigate the feasibility of a prehabilitative training intervention. The intervention includes specific strength and balance exercises during neoadjuvant chemotherapy with children and adolescents diagnosed with soft tissue or bone tumor in the lower extremity. This explorative approach of prehabilitation might help to reduce muscle and bone weakening and associated functional limitations during and after acute therapy. By designing this study like a controlled clinical trials, the investigators will also gather preliminary data on the intervention's potential effects in enhancing/on the pre-operative condition. The goal is to improve post-operative outcome and rehabilitation processes in children and adolescents diagnosed with soft tissue or bone sarcoma of the lower extremity.

Conditions

  • Soft Tissue Sarcoma of the Lower Extremity
  • Bone Tumor of the Lower Extremity
  • Childhood and Adolescent Cancer

Interventions

OTHER

Exercise intervention

Specific strength and balance training intervention during neoadjuvant chemotherapy, twice per week for 30 min, progression according to individual status

Sponsors & Collaborators

  • Dr. von Haunersches Children's Medical Hospital, University of Munich, Germany

    collaborator OTHER

  • Technical University of Munich

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-02-20
Primary Completion
2027-10-30
Completion
2028-03-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06743958 on ClinicalTrials.gov